Fortfahren mit
Größe auswählen
| Ihnen/SKU | Verfügbarkeit | Preis |
|---|---|---|
300 mg | Warenkorb auf Verfügbarkeit prüfen | € 407,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
lithium carbonate
manufacturer/tradename
USP
mp
618 °C (lit.)
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
[Li+].[Li+].[O-]C([O-])=O
InChI
1S/CH2O3.2Li/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2
InChI key
XGZVUEUWXADBQD-UHFFFAOYSA-L
Gene Information
human ... GSK3A(2931), GSK3B(2932), IMPA1(3612)
General description
For further information and support please go to the website of the issuing Pharmacopoeia.
Application
- Lithium Carbonate Capsules
- Lithium Carbonate Tablets
- Lithium Carbonate Extended-Release Tablets
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| manufacturer/tradename USP | manufacturer/tradename NIST® | manufacturer/tradename - | manufacturer/tradename - |
| grade pharmaceutical primary standard | grade certified reference material | grade ACS reagent, puriss. p.a. | grade - |
| format neat | format neat | format - | format - |
| application(s) pharmaceutical (small molecule) | application(s) clinical | application(s) - | application(s) battery precursors |
| Gene Information human ... GSK3A(2931), GSK3B(2932), IMPA1(3612) | Gene Information human ... GSK3A(2931), GSK3B(2932), IMPA1(3612) | Gene Information human ... GSK3A(2931), GSK3B(2932), IMPA1(3612) | Gene Information human ... GSK3A(2931), GSK3B(2932), IMPA1(3612) |
| mp 618 °C (lit.) | mp 618 °C (lit.) | mp 618 °C (lit.) | mp 618 °C (lit.) |
Still not finding the right product?
Explore all of our products under Lithiumcarbonat
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Lagerklasse
11 - Combustible Solids
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

